2015•LeukemiaRequires access

Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study

Valentin Goede, Kirsten Fischer, Anja Engelke, Rudolf Schlag, Stéphane Leprêtre, Luis Felipe Casado Montero, Marco Montillo, Chris Fegan, Elina Asikanius, Katherine G. Humphrey, Günter Fingerle‐Rowson, Michael J. Hallek

Open publisher page 237 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 237 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Obinutuzumab, Chronic lymphocytic leukemia, Medicine, CD20, Leukemia, Internal medicine, Oncology, Antibody